May 2017

Chairman's Letter
Chairman’s Letter
Michael J. Hennessy, Sr
From the Editor
From the Editor
Debu Tripathy, MD
Breast Cancer
Commentary—Redefining HER2-Equivocal Breast Cancers: Lessons Learned from Genomic Pathology
Shelly Gunn, MD, PhD
Gastric Cancer
The Role of Radiotherapy in the Management of Gastric Cancer
Michael C. Repka, MD; Mohamed E. Salem, MD; and Keith R. Unger, MD
Neoadjuvant Chemotherapy
Case Study—Pathologic Complete Response Following a Single Cycle of Neoadjuvant Chemotherapy
Isolina R. Rossi, BS; Paolo Gattuso, MD; Katherine B. Kabaker, MD; Andrea Madrigrano, MD; and Katherine A. Kopkash, MD
Triple-Negative Breast Cancer
Immunotherapy for Triple-Negative Breast Cancer: A Focus on Immune Checkpoint Inhibitors
Isha Dua, MD, and Antoinette R. Tan, MD, MHSc
Oncology Briefings™: Emerging Treatment Options for Patients With High-Risk AML
Harry P. Erba, MD, PhD
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine Tumors
Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant Obstacles
Stephan A. Grupp, MD, PhD
Current Treatment Options in Marginal Zone Lymphoma